Theriva Biologics GAAP EPS of -$2.08
Source: SeekingAlpha
2026-03-12 15:12:39 ET
More on Theriva Biologics
- Seeking Alpha’s Quant Rating on Theriva Biologics
- Historical earnings data for Theriva Biologics
- Financial information for Theriva Biologics
Read the full article on Seeking Alpha
For further details see:
Theriva Biologics GAAP EPS of -$2.08
Theriva Biologics, Inc.
NASDAQ: TOVX
TOVX Trading
-1.22% G/L:
$0.2181 Last:
2,341,670 Volume:
$0.22 Open:
TOVX Latest News
March 23, 2026 09:45:07 am
Regulatory Wins, Capital Flows, and Global Expansion Drive Market Momentum
March 23, 2026 08:00:00 am
Theriva(TM) Biologics Announces Positive End-of-Phase 2 Meeting with U.S. FDA Regarding the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma
March 12, 2026 08:00:00 am
Theriva(TM) Biologics Reports Full-Year 2025 Operational Highlights and Financial Results
February 19, 2026 10:50:56 am
$30M Revenue Rocket, Super Spiders, and Biotech Patent Blitz Launch Morning Momentum
TOVX Stock Data
$6,923,540
35,688,349
3.24%
10
N/A
Biotechnology & Life Sciences
Healthcare
US
Rockville
